[1]
“Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma”, Radiol Oncol, vol. 55, no. 1, pp. 66–76, Feb. 2021, Accessed: Nov. 03, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/3516